Fungemia with Co-isolation of Candida parapsilosis and Trichosporon asahii Confirmed by MALDI-TOF MS and D 2 rRNA Sequencing

eISSN 2093-6338 patients and patients with serious general clinical status [1]. Candida species are currently a major cause of sepsis acquired in health care institutions [2] and the most common cause of blood stream fungal infections [3, 4]. Among Candida species, the incidence of Candida parapsilosis infection has rapidly increased [1]. This species is the second most common pathogen isolated from blood cultures of patients with candidemia in the USA [5]. Several studies of the worldwide incidence of Candida infections have reported that C. parapsilosis is a more common isolate than Candida albicans in some non-US regions [6]. C. parapsilosis is responsible for many clinical diseases such as fungemia [5, 7], endocarditis [8], meningitis [9], and peritonitis [10]. In addition to Candida, Trichosporon species are associated with diverse clinical symptoms, from mild to fatal [11]. Trichosporon species are widely distributed; they are sometimes present on the human body as INTRODUCTION

[1]  Won-Kil Lee,et al.  A Case of Trichosporon asahii Fungemia with Urinary Tract Infection as a Primary Focus , 2015 .

[2]  Mina Kim,et al.  Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea. , 2010, Medical mycology.

[3]  A. Colombo,et al.  Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing , 2009, Journal of Clinical Microbiology.

[4]  S. Suh,et al.  Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea , 2007, Yonsei medical journal.

[5]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[6]  Ronald N. Jones,et al.  International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003) , 2006, Journal of Clinical Microbiology.

[7]  M. Cuenca‐Estrella,et al.  Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 , 2006, Journal of Clinical Microbiology.

[8]  M. Bassetti,et al.  Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.

[9]  L. Pagano,et al.  Design and Methods , 2022 .

[10]  S. Fridkin,et al.  Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community Hospital , 2004, Journal of Clinical Microbiology.

[11]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  D. Kontoyiannis,et al.  Trichosporonosis in a tertiary care cancer center: Risk factors, changing spectrum and determinants of outcome , 2004, Scandinavian journal of infectious diseases.

[13]  T. Boekhout,et al.  Co-isolation of Trichosporon inkin and Candida parapsilosis from a scalp white piedra case. , 2004, Medical mycology.

[14]  T J Walsh,et al.  Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  D. Wolf,et al.  Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units , 2001, Journal of Clinical Microbiology.

[16]  M. Pfaller,et al.  International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program , 2001, Journal of Clinical Microbiology.

[17]  Peggo K. W. Lam,et al.  Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Weems Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Lipton,et al.  Candidal infection in the central nervous system. , 1984, American Journal of Medicine.